October 16, 2024- Baxter International began shipments of intravenous products to the U.S. from two international facilities last week, the company said on Monday. According to Reuters, Baxter has been working to bring the company’s facility in North Carolina back online amid a shortage of the essential medical product.
Baxter has also received the U.S. Food and Drug Administration’s clearance on Oct. 9 to temporarily import medical products from five facilities in Canada, China, Ireland, and the UK, and was working to secure authorization for more sites amid a nationwide shortage following flooding of the plant by Hurricane Helene late last month.